A dual role for tumor-derived chemokine RANTES (CCL5)
- 19 November 2003
- journal article
- research article
- Published by Elsevier BV in Immunology Letters
- Vol. 90 (2-3), 187-194
- https://doi.org/10.1016/j.imlet.2003.09.013
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Altered Chemokine Receptor Sensitivity in FVBN202 Rat neu Transgenic MiceBreast Cancer Research and Treatment, 2003
- Regulation of Dendritic Cell Recruitment into Resting and Inflamed Airway Epithelium: Use of Alternative Chemokine Receptors as a Function of Inducing StimulusPublished by The American Association of Immunologists ,2001
- Chemokine Receptor Desensitization in Tumor-Bearing MiceCellular Immunology, 2001
- Dendritic cell biology and regulation of dendritic cell trafficking by chemokinesSpringer Seminars in Immunopathology, 2000
- Spontaneous mammary carcinomas fail to induce an immune response in syngeneic FVBN202 neu transgenic miceInternational Journal of Cancer, 2000
- The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude miceBritish Journal of Cancer, 1999
- Eradication of Pre-Established Lymphoma Using Herpes Simplex Virus Amplicon VectorsBlood, 1999
- Recent Advances in Chemokines and Chemokine ReceptorsCritical Reviews in Immunology, 1999
- RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of TumorigenicityIn Vivo:Role of Immune Cell SubpopulationsHuman Gene Therapy, 1996
- Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.Molecular and Cellular Biology, 1986